Tumor blood vessels, a difficult hurdle for infiltrating leukocytes

PublicationsRole of Integrins in Tumor Immune Surveillance
Written By Rob Bent

Author & Article Information

  • Authors: Karolien Castermans, Arjan W. Griffioen

  • Angiogenesis Laboratory, Research Institute for Growth and Development (GROW), Departments of Internal Medicine and Pathology, Maastricht University and University Hospital, Maastricht, The Netherlands

  • Published: 15 August 2007

https://doi.org/10.1016/j.bbcan.2007.07.005

Abstract

In spite of a gradual improvement of its therapy, cancer is still a deadly disease for millions of patients. Immunotherapy is one of promising treatment strategies, but several mechanisms counteract the development of a proper anti-tumor immune response and the formation of an effective inflammatory infiltrate. One of the difficult hurdles is the hampered recruitment of leukocytes from the blood into the tumor site. It has been demonstrated that tumor cells evolved mechanisms to escape immunity, based on down regulation of endothelial adhesion molecules. This paper reviews the endothelial cell adhesion molecules that mediate leukocyte recruitment and the regulation of them during tumor development. In addition, an overview will be given of the translational development and clinical application of the specific composition of adhesion molecules on tumor endothelium, in diagnosis and therapy.

See the original article here | El Sevier Science Direct

Rob Bent
Previous

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Next

Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma